What We're Reading: Page 397
Industry reads hand-picked by our editors
Feb 05, 2015
-
BioPharma Dive
UPDATE: Why Gilead's shares are tumbling despite stellar Q4 earnings
-
Zacks
Earnings roundup: Merck tops expectations, steady GSK rises on ViiV IPO talk
-
-
Bloomberg
US to launch large-scale universal flu shot testing in 2016
-
-
-
-
Fierce Pharma
Moody's: Patent-cliff challenges will continue to dog big pharma
-
Merck
Merck's Belsomra for insomnia now available in US
-
WSJ
Another FDA warning letter for India-based Apotex
Feb 04, 2015
-
Reuters
UPDATE: Obama budget proposes historic, direct Medicare drug price negotiations
-
-
in-Pharma Techologist
FTC: Ranbaxy must sell acne drug to Torrent Pharma before Sun takeover
-
-
CNBC
Sanofi finally launches Afrezza inhaled insulin in the US
-
-
Forbes
Chimerix shifts from Ebola focus to adenoviruses, CMV as outbreak wanes
-
WSJ
Ireland threatens to cap drug prices
-
-
FiercePharma
FDA approves new Zohydro ER pankiller formulation
Feb 03, 2015
Feb 02, 2015
-
BioPharma Dive
Obama to unveil $215M personalized medicine, million-person DNA sequencing project
-
-
Reuters
Study: Parkinson's patients' response doubles with 'expensive' placebo
-
-
-
-
-
xconomy.com
Biogen Idec re-enters gene therapy R&D with hemophilia focus
-
Fierce Pharma
J&J under continued scrutiny for off-label pediatric use of Risperdal
-
Pharma Times
Some UK cystic fibrosis patients being denied breakthough treatment
Jan 30, 2015
-
-
Reuters
Largest US health insurer latest to give Harvoni preferred hep C drug status
-
-
Reuters
Study: Parkinson's patients' response doubles with 'expensive' placebo
-
-
Reuters
Pfizer dodges class-action trial with $400 million settlement
-
-
-
Express Scripts Web site
Express Scripts claims it's saved US healthcare $4B through hep C deals
-
FiercePharma
Earnings update: Roche plateaus, Amgen stock slides despite solid performance
Jan 29, 2015
Jan 28, 2015
-
Bloomberg
Expiring patents, surging dollar dog BMS, Pfizer, & Novartis earnings
-
-
Bloomberg
UPDATE: Pfizer gives poor nations modest discount after vax price blowback
-
-
-
FDA
Rumor mill churns as Duke's Dr. Robert Califf appointed FDA deputy commish
-
-
WSJ
Average Rx drug prices spiked 10.9% last year
-
FiercePharma
Novo deploys 500 rep army to take Saxenda message to MDs
-
in-Pharma Techologist
Counterfeit Roche cancer drug smuggler gets 30 months in jail